Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	139.02	161.44	79.93	143.24	47.7	74.85
Short-Term Investments	195.24	196.73	183.51	139.88	118.28	-
Cash & Short-Term Investments	334.26	358.16	263.44	283.11	165.98	74.85
Cash Growth	38.90%	35.96%	-6.95%	70.57%	121.74%	280.94%
Receivables	-	-	-	-	-	12.72
Prepaid Expenses	3.48	3.95	3.99	2.07	0.95	1.16
Other Current Assets	-	-	-	-	-	2.14
Total Current Assets	337.75	362.11	267.43	285.19	166.93	90.87
Property, Plant & Equipment	1.22	1.47	1.03	1.8	1.05	1.18
Other Long-Term Assets	0.35	0.35	0.06	0.04	0.09	0.25
Total Assets	339.32	363.93	268.52	287.03	168.07	92.29
Accounts Payable	2.78	2.15	2.52	1.65	2.13	0.94
Accrued Expenses	7.15	12.62	8.55	5.98	4.34	8.01
Short-Term Debt	-	-	-	-	-	12.88
Current Portion of Leases	0.43	0.43	0.6	0.66	-	-
Other Current Liabilities	0.58	0.46	0.28	0.19	0.36	1
Total Current Liabilities	10.94	15.65	11.94	8.47	6.82	22.82
Long-Term Leases	0.81	0.92	-	0.54	-	-
Other Long-Term Liabilities	1.53	1.49	1.21	1.07	0.95	0.88
Total Liabilities	13.27	18.06	13.15	10.08	7.77	23.7
Common Stock	0.01	0.01	0.01	0.01	0	-
Additional Paid-In Capital	771.37	767.62	588.01	520.18	342.71	14.6
Retained Earnings	-445.39	-421.48	-332.63	-242.42	-182.07	-131.92
Comprehensive Income & Other	0.05	-0.28	-0.02	-0.82	-0.34	-0.12
Total Common Equity	326.04	345.87	255.37	276.94	160.3	-117.44
Shareholders' Equity	326.04	345.87	255.37	276.94	160.3	68.59
Total Liabilities & Equity	339.32	363.93	268.52	287.03	168.07	92.29
Total Debt	1.24	1.35	0.6	1.21	-	12.88
Net Cash (Debt)	333.03	356.82	262.84	281.91	165.98	61.97
Net Cash Growth	38.63%	35.76%	-6.77%	69.84%	167.82%	215.39%
Net Cash Per Share	3.98	4.49	3.69	7.82	7.31	217.33
Filing Date Shares Outstanding	87.34	87.3	64.65	56.67	25.27	25.13
Total Common Shares Outstanding	87.3	87.13	64.58	53.72	25.27	0.34
Working Capital	326.81	346.46	255.49	276.72	160.11	68.05
Book Value Per Share	3.73	3.97	3.95	5.16	6.34	-347.97
Tangible Book Value	326.04	345.87	255.37	276.94	160.3	-117.44
Tangible Book Value Per Share	3.73	3.97	3.95	5.16	6.34	-347.97
Machinery	-	1.36	1.38	1.4	1.3	0.97
Leasehold Improvements	-	0.75	0.73	0.76	0.93	0.9

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q